Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Arthritis Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Arthritis Other
    Efficacy and Safety of Golimumab Treatment Maintained at 52 Weeks in Patients With Psoriatic Arthritis: Reported at ACR-ARHP - (DGDispatch)
    FDA Approves Labeling Changes, Boxed Warning for Efalizumab - (DGNews)
    New ACR Guidelines Update Strategies for Treating RA - (DGNews)
    Abatacept Improves Juvenile Idiopathic Arthritis in Randomised Withdrawal Trial, but Study Design Questioned - (DGNews)
    Zoledronic Acid Better for Bone Remodelling Than Risedronate in Glucocorticoid-Induced Osteoporosis: Presented at EULAR - (DGDispatch)

    News archive

     Recent webcasts/CME - Arthritis Other
      Diagnosis and New Treatments for Gout
      Current Concepts in Pharmacological Management of Juvenile Idiopathic Arthritis
      Current Strategies for the Diagnosis and Management of Spondyloarthropathies
      Inflammatory Arthritis -The Antisynthetase Syndrome
      Inflammatory Arthritis - Gout

      Webcasts/CME archive

       Recent cases - Arthritis Other
        Chronic Tophaceous Gout Presenting as Acute Arthritis During an Acute Illness: A Case Report
        Mycobacterium Tuberculosis Monoarthritis in a Child
        Popliteal Venous Thrombosis in Juvenile Arthritis with Baker Cysts: Report of 3 Cases
        Acute Onset Polyarthritis in Older People: Is it RS3PE Syndrome?
        Symptomatic Hypercalcemia in a Patient with Chronic Tophaceous Gout: A Case Report

        Cases archive
          




        my personal edition > arthritis other > news
        divider

          E-Mail this DGNews to a colleague

        DGNews


        Oral Prednisolone and Naproxen Found Equally Beneficial in the Treatment of Gout Arthritis

          LONDON -- May 29, 2008 -- A recent study, reported in The Lancet, finds that naproxen and prednisolone are beneficial alternatives for nonsteroidal anti-inflammatory drugs and colchicines to treat gout arthritis.

          Primary-care patients with gout were randomly assigned to receive either prednisolone or naproxen for 5 days. Treatment was masked for both patients and physicians. The primary outcome was pain, measured on a 100-mm visual analogue scale and the a priori margin for equivalence set at 10%.

          After 90 hours, the reduction in the pain score was 44.7 mm for prednisolone and 46.0 mm for naproxen. These data suggest that oral prednisolone and naproxen are equally effective in the initial treatment of gout arthritis over 4 days.


          SOURCE: The Lancet




        E-Mail this DGNews to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send